Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis.

Annals of hematology - 1 Feb 2021

Wang Ziqing, Liu Weiyi, Wang Mingjing, Li Yujin, Wang Xueying, Yang Erpeng, Ming Jing, Quan Richeng, Hu Xiaomei

Abstract excerpt

Additional sex combs like 1 (ASXL1) mutations are one of the most common molecular biological abnormalities in patients with primary myelofibrosis (PMF), and the effect of these mutations on prognosis remains controversial. Hence, we conducted a meta-analysis to assess the prognostic value and clinical characteristics of ASXL1 mutations in PMF patients. Eligible studies were systematically searched from PubMed,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Carcinogenesis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Leukemia

Share to Neoplasm Proteins

Share to Primary Myelofibrosis

Share to Sex Factors

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 33386934
DOI: 10.1007/s00277-020-04387-7
PMCID: PMC7817569

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis.PMID 33386934Read ↗

Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis.Semantic proximity Read ↗

Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta-analysis.Semantic proximity Read ↗

Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.Semantic proximity Read ↗

ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival.Semantic proximity Read ↗

Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndromeSemantic proximity Read ↗

Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.Semantic proximity Read ↗

Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value.Semantic proximity Read ↗

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.Semantic proximity Read ↗

[The prognostic value of ASXL1 mutation in primary myelofibrosis. Literature review and clinical case description].Semantic proximity Read ↗

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.Semantic proximity Read ↗

SRSF2 mutation cooperates with ASXL1 truncated alteration to accelerate leukemogenesisSemantic proximity Read ↗

Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.